Companies: 10,795·Total market cap: $144.5T
Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

AXSMNASDAQHealthcare● Active
$232.32
+$0.84(+0.36%)
Market Cap$12.0B
P/E Ratio
52W High$242.41
52W Low$96.09
Overview

Axsome Therapeutics, Inc. (AXSM) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AXSM · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.73axsm eps ttm · axsm earnings per shareEarnings history
PE Ratio (TTM)axsm pe ratio ttm · axsm price to earningsPE Ratio deep dive
Revenue (TTM)$708.2Maxsm revenue ttm · axsm annual revenueFull revenue history
Dividend YieldNo Dividenddoes axsm pay dividends · axsm dividend yieldDividend history
Shares Outstanding49.7Maxsm shares outstanding · axsm floatShares outstanding history
Next EarningsAug 3, 2026Est.axsm earnings date · axsm next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$638.5M▲ +65.55% YoY
202320242025
axsome therapeutics, inc. revenue · axsm revenue 2025
FY 2025Net Income-$183.2M▲ +36.22% YoY
202320242025
axsome therapeutics, inc. net income · axsm profit 2025
FY 2025EPS$-3.68▲ +38.56% YoY
202320242025
axsm eps · axsome therapeutics, inc. earnings per share 2025
TTM:Revenue: $708.2MNet Income: -$188.3MEPS: $-3.73View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy25 analystsis axsm a buy · axsm analyst rating
Strong Buy
0
Buy
24
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$200.00Low
$232.32Current
$255.81Avg Target10.11% upside
$302.00High
axsm price target · axsm 12 month forecast

Total: 25 · Buy rate: 96.0%

The AXSM analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $255.81, representing +10.11% upside from the current price of $232.32.

Stock Performance

Full History
1D+0.36%
1W+3.16%
1M+6.87%
3M+43.12%
YTD+27.20%
1Y+111.45%
5Y+255.23%

About Axsome Therapeutics, Inc.

CEOHerriot Tabuteau
IPO DateNov 19, 2015
Employees712
CountryUS
Websiteaxsome.com

Axsome Therapeutics, Inc. a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline in…

what is axsome therapeutics, inc. · axsm stock overview · axsome therapeutics, inc. company profile · who is axsome therapeutics, inc. ceo · axsm NASDAQ · axsome therapeutics, inc. headquarters · axsome therapeutics, inc. business segments

About Stock Overview & Key Data

Axsome Therapeutics, Inc. (AXSM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 19, 2015. As of the latest trading session, AXSM stock price is $232.32, with a market capitalization of $12.0B. The stock has returned +111.45% over the past 12 months and +27.20% year-to-date.

According to 25 Wall Street analysts, the consensus rating for Axsome Therapeutics, Inc. stock is Buy, with an average 12-month price target of $255.81. In fiscal year 2025, Axsome Therapeutics, Inc. reported revenue of $638.5M and net income of -$183.2M. For detailed data — including Axsome Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Axsome Therapeutics, Inc. (AXSM) stock price is $232.32. The stock is traded on NASDAQ under the ticker symbol AXSM. The 52-week range is $96.09 – $242.41.

AXSM stock priceAXSM quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice